A Next-Generation Technology
for Your Cancer Treatment
We understand that finding the right cancer treatment can be a challenging process. At BioReperia, we’ve developed a solution that may bring you clarity in your treatment journey.
A Next-Generation Technology
for Your Cancer Treatment
Our zebrafish patient-derived tumor xenograft (ZTX®) model is a cutting-edge tool designed to quickly and accurately predict how well different therapies may work for your specific cancer. By using a small sample of your tumor, we test multiple treatment options and provide results in just five days.
This rapid turnaround is possible because tumor cells are injected into zebrafish larvae and treated with various therapies. The results help your oncologist understand which treatments are most effective at killing cancer cells and stopping metastasis and thereby identify the right therapy for you.
We want to reduce cancer mortality for patients
Our goal is to empower you and your medical team with actionable insights, helping convert non-responders into responders and increasing progression-free survival. We are here to support you in navigating your treatment options as efficiently and effectively as possible.
